PeerVoice Head and Neck Cancer CME Hybrid Symposium: After More Than a Decade: Can We Now Enhance Treatment of Patients With LA SCCHN?
This is a hybrid event.
On-site location: Hilton Chicago
Dinner and Registration
Welcome and Introduction
Kevin Harrington, PhD, FRCR, FRCP
Enhancing Outcomes in CRT-Eligible Patients With LA SCCHN: Are We Doing Enough?
Ezra Cohen, MD, FRCPSC, FASCO
Deep Diving the Data for Emerging Therapies in LA SCCHN: A Rational Approach to Improving Outcomes
Barbara Burtness, MD
Emerging Therapies With the Patient in Mind: What Does the Future Hold?Kevin Harrington, PhD, FRCR, FRCP
“Ask the Faculty” and Take-Home Messages
Entire Panel led by Kevin Harrington, PhD, FRCR, FRCP
The Institute of Cancer Research, The Royal Marsden Hospital, London, United KingdomKevin Harrington, PhD, FRCR, FRCP
University of California San Diego, UC San Diego Moores Cancer Center, La Jolla, CaliforniaEzra Cohen, MD, FRCPSC, FASCO